Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N9DS
|
|||
Drug Name |
PMID27607364-Compound-4
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
COCENSYS, INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H13ClN2O
|
|||
Canonical SMILES |
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
|
|||
InChI |
1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3
|
|||
InChIKey |
AAOVKJBEBIDNHE-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 439-14-5
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:49575
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
HTLV-I infection |
References | Top | |||
---|---|---|---|---|
REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.